When hepatic ALAS1 is induced in AIP patients, the half-normal HMBS activity becomes rate-limiting and insufficient to meet the increased heme demand, leading to the depletion of the free heme pool. This evidence concerns the gene ALAS1 and autoimmune pancreatitis.